Breast Cancer Unit, Obstetrics and Gynecology, Women's Health Institute, Hospital Clínico San Carlos, Madrid, Spain.
Clinical Trials and Research Unit, IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Clin Breast Cancer. 2021 Feb;21(1):e128-e135. doi: 10.1016/j.clbc.2020.10.006. Epub 2020 Oct 24.
From the first case of SARS-CoV-2 infection in Wuhan (China), the infection spread all around the world causing a pandemic of coronavirus disease-2019 (COVID-19). Spain has been one of the most severely affected countries, and Madrid has reported a high number of cases and deaths. We discuss our strategies for optimal breast cancer management during COVID-19 pandemic.
This was a retrospective observational study at Clínico San Carlos Hospital to analyze the management of patients with breast cancer during the pandemic outbreak and the surgical strategy after the pandemic outbreak. We created a practical and dynamic tool based on a "traffic light" system for prioritizing surgical time. Every patient was contacted by telephone with a preoperative COVID-19 protocol. After surgical procedures, patient satisfaction was assessed using the European Organisation for Research and Treatment of Cancer in-patient satisfaction with cancer care questionnaire (EORTC IN-PATSAT32).
Patients with breast cancer actively treated with surgical procedures were put on a waiting list and received systemic therapy. Telemedicine was used to evaluate any side effects and to avoid unnecessary hospital visits. Surgery was only considered after the pandemic outbreak, and then, only those procedures designed to minimize surgical complications and, therefore, reduce hospital stay. We also measured patients' satisfaction with medical and nursing scales that resulted in a "very good" evaluation tending to "excellent".
It is necessary to adapt management of oncology treatment and surgical strategy to optimize resources during the COVID-19 pandemic. Patients' perception of care quality and the degree of patients' satisfaction with health services has potential relevance in the absence of outcome data.
自武汉（中国）首例 SARS-CoV-2 感染以来，该感染已在全球范围内传播，导致 2019 年冠状病毒病（COVID-19）大流行。西班牙是受影响最严重的国家之一，马德里报告了大量病例和死亡。我们讨论了在 COVID-19 大流行期间优化乳腺癌管理的策略。
这是对 Clínico San Carlos 医院的一项回顾性观察性研究，旨在分析大流行期间乳腺癌患者的管理以及大流行后手术策略。我们根据“红绿灯”系统创建了一个实用且动态的工具，用于优先考虑手术时间。每个患者都通过电话进行了 COVID-19 术前方案。手术后，使用欧洲癌症研究和治疗组织癌症患者满意度调查问卷（EORTC IN-PATSAT32）评估患者的满意度。
积极接受手术治疗的乳腺癌患者被列入等候名单，并接受了系统治疗。使用远程医疗来评估任何副作用并避免不必要的医院就诊。仅在大流行爆发后才考虑手术，然后仅考虑那些旨在最大程度减少手术并发症并因此缩短住院时间的手术。我们还测量了患者对医疗和护理量表的满意度，结果评估为“非常好”，趋于“优秀”。
在 COVID-19 大流行期间，有必要调整肿瘤治疗管理和手术策略，以优化资源。在缺乏结果数据的情况下，患者对护理质量的感知和对卫生服务的满意度程度具有潜在的相关性。
